Investigation of Transcript Variant 6 of TPD52L2 as a Prognostic and Predictive Biomarker in Basal-Like MDA-MB-231 and MDA-MB-453 Cell Lines for Breast Cancer

Figure 2

Kaplan–Meier curves indicating the OS of breast cancer patients with low and high TPD52L2 levels from the GSE96058 dataset [14]. (a) Kaplan–Meier curves of the OS of all breast cancer patients and patients with different PAM50 subtypes, including basal-like, luminal A, luminal B, Her2, and normal-like subtypes. (b) Kaplan–Meier curves of the OS of all lymph node-positive breast cancer patients and lymph node-positive patients with different PAM50 subtypes, including basal-like, luminal A, luminal B, Her2, and normal-like subtypes (log-rank test, ).

(a)

(b)